Poseida Therapeutics Inc
NASDAQ:PSTX

Watchlist Manager
Poseida Therapeutics Inc Logo
Poseida Therapeutics Inc
NASDAQ:PSTX
Watchlist
Price: 9.5 USD -0.63%
Market Cap: 926m USD

Wall Street
Price Targets

PSTX Price Targets Summary
Poseida Therapeutics Inc

There are no price targets for PSTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Poseida Therapeutics Inc Competitors:
Price Targets
ANAB
AnaptysBio Inc
20% Upside
URGN
Urogen Pharma Ltd
54% Upside
BNTX
BioNTech SE
46% Upside
ALKS
Alkermes Plc
60% Upside
VLA
Valneva SE
80% Upside
SCLP
Scancell Holdings PLC
219% Upside
688363
Bloomage Biotechnology Corp Ltd
10% Upside
BMRN
Biomarin Pharmaceutical Inc
55% Upside

Revenue
Forecast

Revenue Estimate
Poseida Therapeutics Inc

For the last 6 years the compound annual growth rate for Poseida Therapeutics Inc's revenue is 67%. The projected CAGR for the next 4 years is 13%.

67%
Past Growth
13%
Estimated Growth
Estimates Accuracy
32%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Poseida Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
Poseida Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PSTX's stock price target?
Not Available

PSTX doesn't have any price targets made by Wall Street professionals.

What is Poseida Therapeutics Inc's Revenue forecast?
Projected CAGR
13%

For the last 6 years the compound annual growth rate for Poseida Therapeutics Inc's revenue is 67%. The projected CAGR for the next 4 years is 13%.

Back to Top